Cardiovascular safety of the cyclooxygenase-2 selective inhibitor parecoxib sodium: Review of pooled data from surgical studies
Stephan A. Schug, F. Camu, Girish P. Joshi, Sharon Pan, Raymond Cheung
Abstract
Stephan A. Schug, F. Camu, Girish P. Joshi, Sharon Pan, Raymond Cheung
Abstract
1University of Western Australia, Perth, Australia; 2Academisch Ziekenhuis Vrije Universiteit Brussel, Brussels, Belgium; 3University of Texas Southwestern Medical Center at Dallas
OpenAlex reports 9 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
1University of Western Australia, Perth, Australia; 2Academisch Ziekenhuis Vrije Universiteit Brussel, Brussels, Belgium; 3University of Texas Southwestern Medical Center at Dallas
Key concepts: Medicine, Parecoxib, Cyclooxygenase, Pharmacology, Anesthesia, Enzyme, Biochemistry, Chemistry